China's leading provider of precision medical solutions
•Simcere was founded in 2017 with a registered capital of 113917288 yuan. It is a precision medical solution provider under Pioneer Holdings, a leading pharmaceutical group in China.
•By integrating a variety of leading molecular detection platforms and bioinformatics analysis capabilities, it provides medical workers and medical institutions with a decision-making basis for precision medicine in the treatment fields of cancer, autoimmune diseases, infection, pharmacogenomics and other treatment fields.
•By the first half of 2021, the company has covered more than 1900 hospitals, serving more than 10000 person times, and has four R&D and production sites in Beijing, Nanjing and other places, with a total use area of 10000 m2.
•The company has obtained 52 invention patents, including 30 invention publications and 22 invention authorizations.
•The revenue in 2019 is 280 million yuan, and the revenue in 2020 is 320 million yuan.
•In June 2021, SciNova made the first diagnosis of 45 million yuan through Hang Chuang Fund. Coaching securities firm: CITIC Securities.
Tele : 021-31338308
Tele : 021-31338309
Tele : 021-31338310
Fax : 021-31338311
Web: www.scivc.com
Email:newsletter@scivc.com
Add : 26K, #726 West Yan'An Road,Shanghai
Copyright © 2021 SCI SHANGHAI CREATION INVESTMENT